Cheng KK, San Andres C, Salam E, Han J, et al. Rates of 30-Day and 90-Day Readmission Between Genotype-Optimal and Genotype-Suboptimal Antiplatelet Therapy Prescribing After Percutaneous Coronary Intervention. Am J Cardiol 2023;202:218-222.
PMID: 37473671